Auckland-based startup Ubiquitome has become the first Kiwi company to receive funding from the United States government-funded medical research centre National Institutes of Health (NIH) for its rapid Covid-19 testing device.
The amount Ubiquitome received remains confidential, but chief
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
